ZA968764B - Pharmaceutical composition containing a blood-braiPharmaceutical composition containing a blood-brain barrier transport enhancer. n barrier transport enhancer. - Google Patents

Pharmaceutical composition containing a blood-braiPharmaceutical composition containing a blood-brain barrier transport enhancer. n barrier transport enhancer.

Info

Publication number
ZA968764B
ZA968764B ZA9608764A ZA968764A ZA968764B ZA 968764 B ZA968764 B ZA 968764B ZA 9608764 A ZA9608764 A ZA 9608764A ZA 968764 A ZA968764 A ZA 968764A ZA 968764 B ZA968764 B ZA 968764B
Authority
ZA
South Africa
Prior art keywords
blood
composition containing
barrier transport
transport enhancer
braipharmaceutical
Prior art date
Application number
ZA9608764A
Inventor
Hendrikus Boddeke Hend Boddeke
Esteban Pombo Villar Es Villar
Albert Enz Albert Enz
Original Assignee
Novartis Ag Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag Novartis Ag filed Critical Novartis Ag Novartis Ag
Publication of ZA968764B publication Critical patent/ZA968764B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9608764A 1995-10-17 1996-10-17 Pharmaceutical composition containing a blood-braiPharmaceutical composition containing a blood-brain barrier transport enhancer. n barrier transport enhancer. ZA968764B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9521322.9A GB9521322D0 (en) 1995-10-17 1995-10-17 Organic compounds

Publications (1)

Publication Number Publication Date
ZA968764B true ZA968764B (en) 1998-04-17

Family

ID=10782492

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9608764A ZA968764B (en) 1995-10-17 1996-10-17 Pharmaceutical composition containing a blood-braiPharmaceutical composition containing a blood-brain barrier transport enhancer. n barrier transport enhancer.

Country Status (4)

Country Link
AU (1) AU7293896A (en)
GB (1) GB9521322D0 (en)
WO (1) WO1997014439A1 (en)
ZA (1) ZA968764B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6307049B1 (en) 1998-09-30 2001-10-23 The Procter & Gamble Co. Heterocyclic 2-substituted ketoamides
US6300341B1 (en) 1998-09-30 2001-10-09 The Procter & Gamble Co. 2-substituted heterocyclic sulfonamides
DOP2000000107A (en) 1999-12-01 2002-09-16 Agouron Pharmaceutical Inc COMPOUNDS, COMPOSITIONS AND METHODS TO STIMULATE THE GROWTH AND LENGTH OF NEURONS
FR2806626B1 (en) * 2000-03-22 2003-11-28 Centre Nat Rech Scient USE OF MODULATING SUBSTANCES FOR THE EXPRESSION OR FUNCTION OF A PROTEIN INVOLVED IN THE CELL CYCLE FOR THE TREATMENT OR PREVENTION OF ACUTE NEURAL INJURIES
GB0117645D0 (en) * 2001-07-19 2001-09-12 Isis Innovation Therapeutic stratergies for prevention and treatment of alzheimers disease
GB0125443D0 (en) 2001-10-23 2001-12-12 Novartis Ag Organic Compounds
AU2007237187B2 (en) * 2002-07-16 2010-08-05 Biotica Technology Limited Production of polyketides

Also Published As

Publication number Publication date
WO1997014439A1 (en) 1997-04-24
GB9521322D0 (en) 1995-12-20
AU7293896A (en) 1997-05-07

Similar Documents

Publication Publication Date Title
ZA965190B (en) Pharmaceutical composition.
GR3027611T3 (en) Pharmaceutical compositions containing a calcitonin.
ZA967034B (en) Pharmaceutical compositions.
SI0817621T1 (en) Pharmaceutical composition for transdermic delivery
IL193245A0 (en) Pharmaceutical compositions containing an a?? fragment
PH31205A (en) Pharmaceutical composition.
ZA967745B (en) Pharmaceutical formulations.
ZA969722B (en) Pharmaceutical formulations.
GR3032366T3 (en) Pharmaceutical cyclosporin composition.
HK1022271A1 (en) Pharmaceutical aerosol composition.
EP0670716A4 (en) Tastemasked pharmaceutical materials.
HUP9903536A3 (en) Pharmaceutical composition stabilized with a basic agent
HK1027957A1 (en) Pharmaceutical composition.
EP0603717A3 (en) Barrier label.
CY2359B1 (en) Pharmaceutical formulation.
OA09810A (en) Pharmaceutical composition.
ZA989680B (en) Pharmaceutical composition.
ZA968081B (en) Pharmaceutical composition.
IL112639A0 (en) A pharmaceutical composition containing pravastin
ZA968764B (en) Pharmaceutical composition containing a blood-braiPharmaceutical composition containing a blood-brain barrier transport enhancer. n barrier transport enhancer.
ZA967466B (en) Pharmacologically active compound.
ZA987392B (en) Pharmaceutical composition.
EP0684832A4 (en) Microemulsions containing pharmaceutical compositions.
ZA943157B (en) Substituted benzodioxins, a process for their prepration and pharmaceutical compositions containing them.
ZA9610589B (en) Pharmaceutical compounds.